Transungdomar i fokus: aktuell dynamik inom transvård och stöd utanför den

Pride House, Wed 3 Aug 4:00 PM–4:45 PM

From May 2021, Astrid Lindgren's Children's Hospital in Stockholm does not initiate hormonal treatment for their young patients in most cases (except when it is done as part of a clinical study). How does this affect young trans- and non-binary people in the Stockholm region and what type of support is available to them within and outside the healthcare system?

In December 2019, the SBU (Swedish Agency for Health Technology Assessment and Assessment of Social Services) published an overview of the knowledge base which showed a lack of evidence for the long-term consequences of hormonal treatment of children and adolescents with gender dysphoria. In relation to it, Astrid Lindgren Children's Hospital does not initiate hormonal treatment for their patients (effective from May 2021). The hormonal treatment is only allowed to take place in a clinical trial setting that received ethical approval from the EPM (Ethical Review Agency/Swedish Institutional Review Board). This panel explores the challenges that trans youth experience in this period, what support is offered to them by the healthcare system, and how various trans-related projects in different NGOs respond to their needs.


Date/time: Wed 3 Aug 4:00 PM–4:45 PM
Location: Pride House (B2, Plan 1)
Clarion Hotel Stockholm, Ringvägen 98, 118 60 Stockholm
Metro station/bus stop: T-Skanstull
Price: Pride House: Festivalbiljett 600kr, Dagbiljett House 100 kr Köp biljett
Language: Swedish
Type/category: Debate/panel discussion
Organizer: RFSL Stockholm

Stockholm Pride arrangerar Pride House med stöd av